Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Clinical trial NCT01634958 · COMPLETED

Trial details

NCT number: NCT01634958
Sponsor: Leti Pharma GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma Sensitization Against Phleum Pratense Pollen Dose-Finding Study

Start date: 2012-10-01
Primary completion: 2013-04-01
Enrollment: 308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.